Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-07-25 00:00:00 ET · period of report 2024-07-23 · accession 0001415889-24-020108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-25 | 2024-07-23 | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $25.65 | -136.1K | 126.1K | -52% | -$3.49M |
| D | 2024-07-25 | 2024-07-23 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +136.1K | 199.1K | +216% | +$216.4K |
| D | 2024-07-25 | 2024-07-23 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -136.1K | 189.1K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-07-23 | S | D | 63,049 | $27.01 | 63,012 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.07. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2024-07-23 | M | A | 136,124 | $1.59 | 199,136 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2024-07-23 | S | D | 23,075 | $23.25 | 176,061 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2024-07-23 | S | D | 50,000 | $25.05 | 126,061 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.00 and $25.75. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Derivative | Share Option | 2024-07-23 | M | D | 136,124 | $0.00 | 189,147 | D | $1.59 · — to 2025-12-15 | 136,124 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |